Lashing out at Toxicology Reports
“What exactly will Lash and Elsevier do with these 115 problematic papers? I can only expect a painfully inadequate response.” – Sholto David
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
“What exactly will Lash and Elsevier do with these 115 problematic papers? I can only expect a painfully inadequate response.” – Sholto David
“The board’s conclusion is therefore that the deviations regarding figure 2b and 2c in article 1 constitute serious deviations from good research practice”
The sad state of affairs of oncology drug discovery
“Dear colleagues, scientists, check your lab members’ raw data, publications, and dissertations even more thoroughly than before to protect scientific ethics and data integrity and maintain trust in science!” – Ingrid Herr
Sholto David brings you a new true crime story. This time featuring two twisted orthopaedics professors from the University ofContinue Reading
Welcome to the the William Harvey Research Institute in London. Meet two proteges of its founder, the late Nobelist Sir John Vane: Chris Thiemermann and Mauro Perretti. Then meet their own rotten mentees, especially Salvatore Cuzzocrea and Jesmond Dalli.
“The only difficult part might be deciding whether Ken has been intentionally deceptive or wildly incompetent, although the difference in practice doesn’t seem so important.” – Sholto David
Rumour goes that liver researchers Gianfranco Alpini and his lady friend Heather Francis left Indiana University. While they remain silent, their PubPeer record speaks volumes.
“Yup we are being hounded.” – Thomas Südhof
“…the best evidence for the existence of VSELs is the dismal failure of all the other much-vaunted stem-cell therapies to deliver on their promises. Since it is axiomatic that some stem-cell therapy must work, the successful cell-types must be the ones that haven’t been tried yet, which leaves VSELs.”- Smut Clyde









